PAK2 and head and neck squamous cell carcinoma: Upregulation of c-Myc expression by PAK2, leading to transcriptional activation and induction of pyruvate kinase M2 (PKM2) expression, has been identified as resulting in the diminished aerobic glycolysis, proliferation and chemotherapeutic resistance of HNSCC cells [99].